Related Experiment Video
Updated: Jun 9, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Multiresistant Gram-negative infections: a global perspective
Jennifer Ho1, Paul A Tambyah, David L Paterson
1National University Hospital Singapore, Department of Infectious Diseases, Singapore, Singapore. jho@gmp.usyd.edu.au
Purpose Of Review:
Multiresistant Gram-negative infections are an increasing problem in hospitals and healthcare facilities worldwide. While much attention has been paid to Gram-positive pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus lately, the importance of Gram-negative nosocomial infections has also been recognized globally.
Recent Findings:
Recent reports have described the spread of carbapenemase-producing Klebsiella pneumoniae across North America. In addition, many strains of Pseudomonas and Acinetobacter in Asia are resistant to all known antibiotics. The global epidemiology of multiresistant Gram-negative pathogens seems to vary by continent. There are very few existing agents which can be used for these pathogens and there are limited options on the horizon. This limited therapeutic armamentarium has been an impetus for novel approaches including combination therapies and increased attention to infection control and prevention efforts.
Summary:
Clinicians need to be aware of the rising problem of resistance in nosocomial and community-acquired Gram-negative pathogens. Novel agents are urgently needed to combat these infections and innovative infection control strategies need to be devised to protect our vulnerable patients.
Insights
Multiresistant Gram-negative infections are a growing global threat, particularly in healthcare settings. Urgent development of new antibiotics and infection control strategies is crucial to combat these resistant pathogens.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Multiresistant Gram-negative infections pose a significant and increasing threat in healthcare facilities worldwide.
- While Gram-positive resistant pathogens receive attention, Gram-negative nosocomial infections are globally recognized as a critical issue.
Purpose of the Study:
- To highlight the escalating problem of multiresistant Gram-negative pathogens.
- To underscore the urgent need for novel therapeutic agents and innovative infection control strategies.
Main Methods:
- Review of recent global reports on the epidemiology of multiresistant Gram-negative pathogens.
- Analysis of current therapeutic options and future prospects for treatment.
Main Results:
- Carbapenemase-producing Klebsiella pneumoniae is spreading across North America.
- Multiresistant strains of Pseudomonas and Acinetobacter are prevalent in Asia, with limited antibiotic options.
- Global epidemiology of these resistant pathogens varies significantly by region.
Conclusions:
- Clinicians must be aware of the rising resistance in both nosocomial and community-acquired Gram-negative infections.
- There is an urgent need for novel antimicrobial agents to treat these infections.
- Innovative infection control strategies are essential to protect vulnerable patient populations.
More Related Videos
08:04Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
Published on: February 8, 2019
08:19Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Related Concept Videos
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Microbiota Modulation by Antibiotics
Acute Pyelonephritis II: Diagnostic Studies and Management
Antimicrobial Effectiveness